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level was observed after flexible CS (p < 0.001). Multivari-
ate analysis supported the hypothesis of patients benefiting 
from flexible CS in terms of pain perception, anxiety symp-
toms, and SS.
Conclusions Our study demonstrates the superiority of 
flexible CS in terms of pain alleviation, and shifts in SS and 
anxiety levels.
Keywords Cystoscopy · Bladder cancer · Sexual 
satisfaction · Depression · Anxiety · Pain
Introduction
Bladder cancer (BC) is one of the most common and lethal 
cancers worldwide [1, 2]. BC diagnosis and surveillance is 
mainly based on endoscopic cystoscopy (CS). Despite BC 
diagnosis, CS is commonly used by the urologists to evalu-
ate haematuria, voiding symptoms, and for minor proce-
dures, such as foreign body removal.
CS is a procedure, which allows visualization of the ure-
thra and the bladder walls. There are two main types of CS: 
rigid and flexible. Traditionally, CS is performed by means 
of a rigid, hollow, steel tube (cystoscope) equipped with a 
lens, that is introduced through the urethra into the blad-
der. Flexible CS, similarly to gastroscopy or colonoscopy, 
is based on flexible composite cystoscopes which have 
actively deflecting tip. Elastic body of flexible cystoscope 
adapts to a certain extent to the contour of the lower uri-
nary tract and, therefore, is less traumatic. Both flexible 
and rigid tools were demonstrated to have equal efficacy 
[3, 4]. Rigid tools offer good irrigant flow and handiness 
along with wide working channel lumen. Flexible cysto-
scopes provide more possibilities for patient positioning, 
enable easy course over an elevated bladder neck or median 
Abstract 
Purpose Bladder cancer (BC) is one of the most com-
mon cancers worldwide. BC diagnosis and surveillance is 
based on cystoscopy (CS). CS impact on patient’s depres-
sion, anxiety, and sexual satisfaction (SS) is not sufficiently 
studied. There are no data on patient’s comfort with flexible 
or rigid CS.
Methods We prospectively evaluated pain perception 
(PP), depression, anxiety, and SS of 100 male patients who 
previously underwent at least one rigid CS in our depart-
ment as surveillance after TURB procedure due to non-
muscle-invasive BC and were scheduled for the next CS 
examination. The patients were randomized for flexible or 
rigid CS. Before CS, patients described their recalled rigid 
CS-related pain by NRS and fulfilled HADS and SS ques-
tionnaires. After CS, PP was re-evaluated immediately and 
HADS and SS within 7–10 days following the CS.
Results The baseline scores include 5.2 ± 2.6 points for 
rigid CS recalled pain, 7.2 ± 3.0 points for HADS anxiety, 
5.8 ± 3.5 for depression, and 27.8 ± 5.1 for SS. The flexible 
CS-related pain was approximately three times lower than 
the recalled pain level and also than the current rigid CS 
related (p < 0.001). Mean SS score was two points lowered 
after rigid CS (p < 0.001). One point decrease in anxiety 
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lobe, facilitate full inspection of the bladder mucosa, and, 
what is the most important, significantly improve patient 
comfort [5]. Urologists often repeat an argument that rigid 
cystoscopes offer a better image quality. However, with the 
video HD cystoscopes that have been introduced recently, 
the image quality greatly exceeds the one obtained by the 
traditional rigid tools.
Despite the evident CS benefits, it has been shown that 
CS is an invasive procedure that is perceived as burdensome 
and is associated with pain and discomfort [6–8]. Because 
of that, in some cases, discomfort leads to the avoidance or 
total abandonment of the cystoscopic surveillance.
It is crucial to concern quality of life in patients with 
BC, as BC is a disease which always requires long, staged, 
repeated and mutilating treatment with a life time period 
of cancer monitoring [9]. The consequences of manipula-
tion on genitourinary tract include psychological problems, 
such as anxiety about losing masculinity, lowered self-
esteem, and lowered sense of sexuality, anxiety about the 
quality of intimate relationships with a partner, and lack of 
acceptance of one’s body.
Only a few studies analysing patient ailments during and 
after CS are available. However, they are based on hetero-
geneous groups of patients and/or disorders and they are 
mainly retrospective or cross-sectional studies [10–12]. 
Most literature concerning patient quality of life or mental 
health addresses muscle-invasive BC patients, who previ-
ously underwent radical cystectomy. These studies focus on 
the effect of different urinary diversion methods [13–15]. 
Only a few analyse patients with non-muscle-invasive blad-
der cancer (NMIBC) [16, 17].
There are not enough objective data regarding CS 
impact on patient’s depression, anxiety, and sexual satisfac-
tion. There are also no data to demonstrate authoritatively 
superiority of either flexible or rigid CS. We neither know 
how the psychological features affect pain perception dur-
ing CS [12, 18].
Aim
In this study, we prospectively evaluated pain perception 
and shift in depression, anxiety, and sexual satisfaction 
(SS) levels in men undergoing cyclic CS assessment with 
rigid and flexible instruments after transurethral resection 
of non-muscle-invasive bladder tumour (TURB).
Methods
An institutional ethics committee approved the study, and 
all patients gave written informed consent.
Study design
We prospectively evaluated pain perception, depression, 
anxiety, and sexual satisfaction of male patients who under-
went at least one rigid CS at the Urology and Urologic 
Oncology Department of Wroclaw Medical University as 
regular surveillance after TURB procedure due to NMIBC 
and who were scheduled for the next CS procedure. Exclu-
sion criteria involved patients under 18 years, with indwell-
ing catheters, with history of any but TURB surgery on 
genitourinary tract, CS with intervention, symptomatic uri-
nary tract infection, and inability to cooperate with psycho-
logical evaluations. Patients taking medications that could 
affect their mental states were also disqualified.
All male patients that were scheduled for cystoscopy 
in our department and who meet inclusion criteria were 
invited to the study. Twenty three patients were not able to 
fill the initial questionnaires, and they were not included 
in the randomization process. Those, who did not provide 
SS responses, but filled HADS and PP questionnaires, 
were included in the study. The patients were randomly 
appointed to undergo flexible CS (group F) or rigid CS 
(group R). We used a statistical package to generate a ran-
dom group assignment for the prospective enrolment. The 
study was single-blinded; patients did not know which pro-
cedure will be performed at the time they completed the 
first set of questionnaires. Seventeen patients did not resend 
the second set of the questionnaires and were excluded 
from the study. The study enrolment was stopped after both 
the study groups reached the expected size of 50 partici-
pants (100 patients in total).
Cystoscopy
All procedures were performed at the Urology and Uro-
logic Oncology Department of Wrocław Medical Univer-
sity. One urologist (WK) conducted all flexible procedures 
and the majority of rigid CSs. All CSs were performed in 
the dorsal lithotomy position. All CSs started with routine 
disinfection of external genitalia and perineum with anti-
septics agent. Instillation of a lubricating gel containing 2% 
lidocaine was performed at least 5  min before endoscope 
insertion. All CSs were carried out without any systemic 
sedation or analgesia. All endoscopes were introduced and 
advanced under direct operator vision. Rigid Storz 20  Fr 
and flexible 15  Fr ACMI cystourethroscope were used. 
Patients had the opportunity to observe CS on the screen. 
No antimicrobial prophylaxis was used routinely.
Statistical analysis
Based on the preliminary assessment of the NMIBC 
patients (data not shown), 100 patients were calculated to 
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be sufficient to observe at least 25% decrease in pain level 
after flexible CS, assuming alpha 0.05 and power of 0.80.
The numerical results are presented as mean  ±  stand-
ard deviation. Group comparison was analysed with 
Mann–Whitney test. The paired observations, pre- and 
post-CSs, were compared using Wilcoxon signed-rank test. 
The variations of frequencies were tested using χ2. The 
correlations were assessed with Spearman or gamma cor-
relation. The rs values of 0.20–0.39 were considered weak, 
0.40–0.59 moderate, and >0.60 strong associations. γ of 
0.25–0.49 was considered a weak, 0.50–0.74 a moderate, 
and >0.75 a strong relationship.
The Bonferroni correction for multiple testing was 
applied when appropriate, and the adjusted p values are 
shown in the paper. The value of adjusted p  <  0.05 was 
considered statistically significant.
General regression model of ANCOVA was used for 
multivariate analysis. The type of cystoscope used during 
the study procedure was modelled as 1 for rigid and 0 for 
flexible one.
All calculations were performed with Statistica v.12 
(Statsoft, Poland).
Pain perception
Patient’s pain perception was assessed with numeric rating 
scale (NRS) [19]. An 11-point scale, ranging from 0 (free 
from pain) to 10 points (unbearable pain), was used. Before 
the CS procedure, patients were asked to evaluate the 
recalled pain related to the previous rigid CS. Pain expe-
rienced during the current CS was estimated within a few 
minutes after the CS.
Psychological questionnaires
The questionnaires were completed before CS in a room 
that provided privacy. After CS, patients were discharged 
with an addressed and stamped envelope containing the 
second copy of questionnaires, which was to be completed 
7–10 days following the CS and resent to our depart-
ment. Patients who did not complete Hospital Anxiety and 
Depression Scale (HADS) questionnaires or completed 
HADS/SS questionnaires partially were excluded from the 
analyses. Patients who did not resend copies of surveys 
were also disqualified.
Hospital anxiety and depression scale (HADS)
Anxiety and depression were measured with the validated 
‘Hospital Anxiety and Depression Scale’ (HADS) [20]. 
The HADS, presented by Zigmond and Snaith, has been 
translated, tested, and used in various languages, includ-
ing Polish [21]. This is a widely used tool, suitable for 
different kinds of patients, including those with both can-
cerous and non-cancerous diseases. As the items of the 
questionnaire are not concentrated on severe symptoma-
tology, the scale is applicable to the general population 
samples [22].
The HADS consists of two subscales with seven items 
scored 0–3 each, rating anxiety (HADS-A) and depres-
sion (HADS-D), respectively. Based on individual sums 
of scores, patients can be assigned to one of the three cat-
egories: non-case/normal (0–7), borderline case (8–10), 
and definite case (11–21) for both depression and anxi-
ety. Due to high sensitivity and specificity in detecting 
the generalized anxiety and depression symptoms, HADS 
is one of the most frequently used screening tools in 
medical conditions [21, 23]. HADS is a valid and reli-
able screening instrument both on aggregate European 
level and on country-specific level and can, therefore, be 
administered to patients across languages, countries, and 
institutions [24, 25]. The polish version of HADS con-
ducted on gynaecological patients presented good inter-
nal consistency with Cronbach’s coefficient alpha at 0.84 
and 0.78 for depression and anxiety subscales, respec-
tively, and 0.88 for the whole questionnaire [21].
The sexual satisfaction questionnaire
Sexual satisfaction was measured with The Sexual Sat-
isfaction Questionnaire designed by Nomejko and 
Dolińska-Zygmunt. This tool was designed for adults 
at all ages and it allows to measure a patient’s attitude 
(cognitive and emotional) towards their own sexual activ-
ity [26]. The Sexual Satisfaction Questionnaire is used 
to measure the sense of sexual satisfaction associated 
with two areas: sexual attractiveness of the individual 
and sexual activity. The questionnaire allows to look at 
human sexuality from the perspective of life’s quality of 
[27]. The questionnaire consists of ten statements, and 
the answers are provided using four-point Likert scale: 
Table 1  Sexual Satisfaction Questionnaire questions [28]
1. I am disconcerted with a part of my sexual life
2. Sex is a source of pleasure for me
3. Thinking about sex generates negative emotions
4. I feel sexually attractive
5. I find myself a poor sexual partner
6. I do not have any problems in my sexual life
7. I like thinking about my sexual life
8. My sexual life frustrates me
9. I am afraid I do not satisfy my sexual partner
10. I find my sexual life fulfilling
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1—absolutely not, 2—rather not, 3—rather yes, and 4—
definitely yes [28] (Table  1). A result of the question-
naire is the sum of points. Questions 1, 3, 5, 8, and 9 
are encoded inversely. The theoretical distribution of the 
results fits within the 10–40 range. The method does not 
have the reference levels. The result is interpreted in rela-
tion to the examined population.
It was shown by that SS level measured by SS question-
naire is positively correlated with the quality of life. The 
r-Pearson coefficient of SS and global quality of life corre-
lation was: r  = 0.453; p < 0.001. In addition, the SS ques-
tionnaire presented good internal consistency with Cron-
bach’s coefficient alpha at 0.83 [26].
Results
The study involved 100 male NMIBC patients who were 
scheduled for the consecutive cystoscopy as a regular sur-
veillance after TURB procedure. The patients who fulfilled 
the study criteria were randomly assigned into rigid or 
flexible CS group differing in CS procedure applied. The 
groups were proved to be age and baseline scores matched 
(Table 2).
The recalled pain perception
The mean recalled pain level experienced during the previ-
ous rigid CS was 5.7 ± 2.4 points, with full 0 ÷ 10 range of 
responses. In the univariate analysis, a weak positive asso-
ciation of the recalled pain with depression score (rs = 0.33, 
p = 0.008) and weak negative correlation with sexual satis-
faction (rs = −0.40, p = 0.002) were observed. The level of 
the recalled pain was not related to the patients’ age, and 
did not associate with the anxiety level (Table 3).
Pain perception during the study CS – group 
comparison
The mean pain level experienced during the current rigid 
CS was 5.2 ± 2.6 points, with full 0 ÷ 10 range of responses 
(Table 4). The level of the currently experienced pain was 
Table 2  Baseline study group characteristics
a Mann–Whitney test p value
b χ2 test p value; all p values were adjusted for multiple testing; the results are presented as mean ± SD [range] or proportion [number of cases/
total number]
Combined Rigid CS Flexible CS Group 
comparison, 
p value
Age 69.0 ± 7.3 years [48 ÷ 86 years] 68.5 ± 7.8 years [48 ÷ 86 years] 69.5 ± 6.8 years [55 ÷ 83 years] p = 1.000a
Pain perception 5.7 ± 2.4 [0 ÷ 10] 5.5 ± 2.8 [0 ÷ 10] 5.9 ± 2.0 [2 ÷ 10] p = 1.000a
HADS—anxiety 7.2 ± 3.0 [1 ÷ 13] 7.5 ± 3.0 [1 ÷ 13] 6.8 ± 3.0 [1 ÷ 13] p = 1.000a
HADS—anxiety qualitative p = 0.944b
 Borderline 32% [32/100] 36% [18/50] 28% [14/50]
 Definite 18% [15/100] 18% [9/50] 12% [6/50]
HADS—depression 5.8 ± 3.5 [0 ÷ 14] 5.9 ± 3.7 [0 ÷ 14] 5.7 ± 3.3 [0 ÷ 12] p = 1.000a
HADS—depression qualitative p = 1.000b
 Borderline 30% [30/100] 30% [15/50] 30% [15/50]
 Definite 9% [9/100] 10% [5/50] 8% [4/50]
SS questionnaire completed 85% [85/100] 86% [43/50] 84% [42/50] p = 1.000b
Sexual satisfaction 27.8 ± 5.1 [16 ÷ 40] 28.4 ± 4.8 [20 ÷ 40] 27.4 ± 5.4 [16 ÷ 37] p = 1.000a
Table 3  Correlations observed 
at baseline (pre-CS)





rs p value rs p value rs p value rs p value
Recalled pain perception 0.05 1.000 0.33 0.008 0.19 0.617 −0.40 0.002
Sexual satisfaction −0.39 0.002 −0.56 <0.001 r − 0.48 <0.001
HADS—anxiety 0.19 0.611 0.51 <0.001
HADS—depression 0.35 0.003
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similar to the recalled pain level. The pre- and post-CSs 
provided that responses were moderately correlated with 
γ = 0.56 (p < 0.001). The pain perception was slightly influ-
enced by a result of the current CS. The positive CS, i.e., 
with visualization of tumour recurrence or suspicion of 
tumour recurrence, was described as 6.5 ± 2.3, range 3 ÷ 10, 
and negative as 4.6 ± 2.5, range 0 ÷ 9 (p = 0.039).
In case of flexible CS, the currently experienced pain 
level was much lower than the recalled rigid CS level with 
the mean score of 1.7 ± 1.2, range 0 ÷ 5 (p < 0.001, Table 4). 
The pain related to flexible CS was also much lower than 
the current pain perception in the group R (p < 0.001). 
Despite overall lowering of the responses, the recalled and 
post-CS provided that responses remained weakly cor-
related with γ = 0.31 (p = 0.032). The result of flexible CS 
did not influence the pain perception level. The drop in 
pain perception observed during flexible CS was not related 
to any of the assessed scores nor patients’ age (data not 
shown).
Analysis of covariance showed that pain perception 
during CS is mostly influenced by the type of the cysto-
scope (β = 0.67, p < 0.001), but also by the recalled pain 
level reflecting the patients’ pain susceptibility (β = 0.46, 
p < 0.001) and slightly by the current anxiety HADS level 
(β = 0.16, p = 0.036). Patients’ age, depression symptoms, 
and the CS result were not independently influencing the 
pain level.
HADS in NMIBC patients
The questionnaires’ results provided before the CS pro-
cedure were considered a baseline characteristics of the 
patients involved in the study. The mean anxiety score 
was 7.2 ± 3.0 points with 32% of the study group present-
ing borderline anxiety and 18% definite anxiety. The mean 
depression score was 5.8 ± 3.5 points, with 30% borderline 
and 9% definite depression observed.
The HADS score results were associated and influ-
enced by patients’ age (Table  3). There was a moderate 
positive correlation between anxiety and depression 
(rs = 0.51, p < 0.001) and depression but not anxiety was 
shown to be age related (rs = 0.35, p = 0.003).
In multivariate analysis, depression symptoms were 
the only one to associate with the initial HADS anxiety 
level (β = 0.51, p < 0.001). Patients’ age and the recalled 
pain did not appear to have an impact on the anxiety 
score.
HADS scores: short‑term response after CS with group 
comparison
The type of the cystoscope used for bladder examination 
influenced the post-CS reported anxiety. The mean anxi-
ety HADS score provided 7–10  days after rigid CS was 
7.4 ± 3.2 points, range 0 ÷ 15 and was similar to pre-CS 
result. In the case of flexible CS, the mean anxiety HADS 
score reported 7–10  days post-CS was 5.9 ± 3.1 points, 
range 0 ÷ 11, and was lower when compared to pre-CS level 
(p < 0.001, Table 4).
The mean depression score was 6.1 ± 3.4 points, range 
0 ÷ 15 for rigid CS and 5.6 ± 3.5 and range 0 ÷ 13 after flex-
ible one (Table  4). The score was comparable to pre-CS 
assessment in both groups.
The anxiety and depression HADS results assessed 
pre- and post-CSs were strongly correlated in both groups 
(Table 5), and they were not influenced by the current CS 
result.
When corrected for covariance, post-CS anxiety was 
mostly defined by the baseline anxiety level (β = 0.77, 
p < 0.001), but also some negative impact of the rigid CS 
(β = 0.12, p = 0.090) and baseline depression (β = 0.11, 
p = 0.087) could be observed.
Post-CS depression was described very similarly to the 
first assessment (β = 0.79, p < 0.001) with slight impact of 
the initial anxiety (β = 0.16, p = 0.004).
The experienced pain level and patients’ age did not have 
a direct effect on the anxiety nor depression level post-CS.
Table 4  Study group scores reported after the current CS
Statistically significant values (p < 0.05) are given in bold
a Wilcoxon test p value
b Mann–Whitney test p value; all p values were adjusted for multiple testing
Score Rigid CS group Flexible CS group Group 
comparison, 
p valuebMean ± SD [range] Post-CS to baseline, 
p valuea
Mean ± SD [range] Post-CS to baseline, 
p valuea
Pain perception 5.2 ± 2.6 [0 ÷ 10] 1.000 1.7 ± 1.2 [0 ÷ 5] <0.001 <0.001
HADS—anxiety 7.4 ± 3.2 [0 ÷ 15] 1.000 5.9 ± 3.1 [0 ÷ 11] <0.001 0.156
HADS—depression 6.1 ± 3.4 [0 ÷ 15] 1.000 5.6 ± 3.5 [0 ÷ 13] 1.000 1.000
SS 26.4 ± 5.1 [14 ÷ 35] < 0.001 27.1 ± 4.7 [18 ÷ 36] 1.000 1.000
630 Qual Life Res (2017) 26:625–634
1 3
NMIBC patients’ sexual satisfaction scores
The mean SS score reported initially by the study par-
ticipants was 27.8 ± 5.1. There was a group of patients, 
who did not fill the SS questionnaire. They were older 
(SS−: 75.1 ± 4.3  years, range 69 ÷ 83  years; SS+: 
67.9 ± 7.2  years, range 48 ÷ 86; p < 0.001) but did not 
differ in terms of anxiety, depression, or pain perception 
from other study participants.
Both anxiety and depression negatively correlated 
with sexual satisfaction score (rs = −0.46, p < 0.001 and 
rs  =  −0.56, p < 0.001, respectively). There was a weak 
negative association of sexual satisfaction with patients’ 
age (rs = −0.39, p = 0.002).
Multivariate analysis, including age, HADS, and PP 
scores, showed that baseline SS score was negatively 
influenced by the baseline anxiety (β = −0.27, p = 0.012), 
depression symptoms (β = −0.24, p = 0.043), and recalled 
pain perception (β = −0.22, p = 0.020).
Sexual satisfaction after CS
Mean SS score after the current rigid CS was 26.4 ± 5.1, 
range 14 ÷ 35, and its level was slightly but significantly 
lowered compared to pre-CS value (p < 0.001, Table  4). 
Mean SS score after flexible CS was 27.1 ± 4.7, range 
18 ÷ 36, and its level was not influenced by the CS 
procedure.
SS after the current CS was not associated with pain 
perception (Table  5). In addition, the change in SS was 
not related to pain perception nor patients’ age. As it was 
observed at baseline, SS was negatively related in both 
groups to depression and in case of rigid CS, also the 
negative influence of anxiety on SS was observed. The 
patients’ age moderate negative association with SS was 
observed in group F (rs = −0.55, p = 0.003), but was not 
observed in group R.
Sexual satisfaction scores provided that post-CSs were 
strongly associated with the previously described base-
line SS level (β = 0.90, p < 0.001), but also a negative 
Table 5  Factors influencing the 
HADS and SS scores post-CS—
single effects and analysis of 
covariance
Statistically significant values (p < 0.05) are given in bold
a Value of 1 for rigid CS in multivariate analysis
b Recalled not current pain perception was included in the multivariate model to assess the patients’ 
pain sensitivity and due to very strong association of experienced pain and type of CS; all p values were 
adjusted for multiple testing
Score Single correlations Analysis of 
covariance
Group R Group F β p value
Predictors Corr. coeff p value Corr. coeff p value
HADS—anxiety
 Type of the  CSa – – – – 0.12 0.090
 Baseline anxiety γ= 0.70 <0.001 γ= 0.90 <0.001 0.77 <0.001
 Baseline depression rs = 0.49 0.001 rs = 0.54 <0.001 0.11 0.087
 Current pain perception rs = 0.24 1.000 rs = 0.32 0.444 – 0.531
 Age rs = 0.28 0.735 rs = 0.14 1.000 – =0.639
HADS—depression
 Type of the  CSa – – – – – 0.721
 Baseline anxiety rs = 0.53 <0.001 rs = 0.64 <0.001 0.16 0.004
 Baseline depression γ= 0.83 <0.001 γ= 0.80 <0.001 0.79 <0.001
 Current pain perception rs = 0.21 1.000 rs = 0.20 1.000 – 0.652
 Age rs = 0.33 0.310 rs = 0.38 0.093 – 0.324
Sexual satisfaction
 Type of the  CSa – – – – −0.15 0.001
 Baseline SS γ= 0.84 <0.001 γ= 0.84 <0.001 0.90 <0.001
 Current anxiety rs = −0.45 0.033 rs = −0.40 0.125 – 0.356
 Current depression rs = −0.56 0.001 rs = −0.44 0.048 – 0.632
 Recalledb pain perception rs = −0.33 0.480 rs = −0.49 0.015 – 0.643
 Current pain perception rs = −0.08 1.000 rs = −0.55 0.003
 Age rs = −0.22 1.000 rs = −0.37 0.224 – 0.658
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impact of the rigid CS (β = −0.15, p = 0.001) could be 
observed in the multivariate analysis.
Discussion
In our study, we measured pain perception and changes 
in anxiety, depression, and sexual satisfaction levels in a 
homogenous group of 100 male patients who were under 
cyclic surveillance after TURB because of NMIBC. Differ-
ences between rigid and flexible CS were analysed in the 
course of the study. Our study was blinded; patients were 
not aware what type of CS would be performed at the time 
they completed the survey. We chose to assess pain, depres-
sion, anxiety, and SS levels not more than 10 days follow-
ing procedure. It has been already proven that the biggest 
changes can be observed in a short time after surgery and 
differences gradually disappear over days [25, 29].
Pain perception
Similar to our previous study, it was shown that pain sensa-
tion remembered by patients from the previous CS is high 
(mean 5.7 ± 2.4 points) often reaching ten points, which is 
quoted as “unbearable pain” [5]. The level of the recalled 
pain was not related to the patients’ age and HADS anxiety 
level; however, it was positively associated with depression 
symptoms.
During the current CS, it was demonstrated that pain 
associated with flexible CS was three times lower (mean 
1.7 ± 1.2) than reported after rigid CS (mean 5.2) inde-
pendently of patients’ age. In addition, no one patient after 
flexible CS rated pain perception for more than five points, 
whereas after rigid CS, eight patients rated pain as severe 
(8–10 points).
The recalled and current pain perception scores are cor-
related, even in the case of observed pain decrease after 
flexible CS. It suggests that patients have a given suscepti-
bility to pain perception, regardless of a performing physi-
cian and the cystoscope type.
A rigid CS with a positive result, i.e., visualization of 
tumour recurrence or suspicion of tumour recurrence, 
was more painful than the negative one. Positive rigid CS 
may be more painful due to the fact that suspicious areas 
are always meticulously visualized, thereby increasing the 
amount of cystoscope manipulation and often CS time. 
There was no difference in pain perception caused by the 
flexible CS result, which also supports the superiority of 
the flexible cystoscope.
In addition, mental syndromes may interfere with inva-
sive examinations resulting in greater pain perception [30]. 
We observed that, although the pain perception during CS 
is mostly influenced by the type of the used cystoscope and 
patients’ pain susceptibility, it is further influenced by the 
anxiety score but not patients’ age.
In many patients, the anticipation of pain caused by CS 
can be a sufficient motive not to undertake primary diagno-
sis or waive the cyclic surveillance after TURB. This rela-
tionship is likely to be particularly pronounced in patients 
with psychological disorders [31–33]. For that reasons, 
patients who are particularly sensitive to pain should be 
referred to a hospital, where it is possible to perform flex-
ible CS. In addition, rigid CS under general/spinal anaes-
thesia is an option, but it is related to higher cost and higher 
risk of complications and cannot be performed in an outpa-
tient setting [34].
Anxiety and depression
It has been proved that oncological patients have increased 
anxiety and depression levels compared to general popula-
tion [22]. It has also been shown that a large proportion of 
patients with BC undergoing radical cystectomy experi-
ence psychological distress during the perioperative period 
[35]. Our observations confirm the hypothesis that HADS 
scores are also higher in NMIBC patients’ population. The 
reported anxiety level was related to depression symptoms 
with no independent influence of patients’ age.
There are no available data on anxiety and depression 
levels measured by HADS scale in general Polish popu-
lation. In somehow similar German population, the mean 
scores for anxiety and depression in males are 4.4 and 4.8. 
Using the cutoff 8+, the percentages of elevated anxiety 
and depression in the total sample are 21 and 23%, respec-
tively [36]. In the case of Polish oncological patients, it was 
documented that in population with gynaecological and 
breast cancers, the average anxiety was ranging from 7.0 
to 8.2, and average depression from 6.1 to 8.4 depending 
on disease stage and therapeutic method [37, 38]. In Polish 
patients with gastrointestinal tract cancers, it was found that 
the average severity of anxiety was 6.7 and average severity 
of depression was 4.8 [39].
In Polish population of testicular cancer, average sever-
ity of anxiety was 5.71. The prevalence of anxiety disorder 
(8–10 pt.) was 40% and anxiety syndrome (11+ pt.) −15% 
in patients during chemotherapy [40].
We observed that the level of anxiety reported after a 
few days post-CS is positively influenced by flexible CS. 
This observation could be explained by the fact that less 
pain during CS not only allows to quickly reduce psycho-
logical tension after procedure, but also gives insights 
that the future surveillance can be less burdensome. What 
was similar with Seklehner et  al. conclusions, depression 
levels did not change after CS notwithstanding the used 
method [25]. Furthermore, the anxiety and depression lev-
els were not influenced by the current CS result. What is in 
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accordance with earlier findings, BC diagnosis might have 
a limited influence on anxiety and depression short time 
following CS [41, 42].
Some authors state that HADS levels are “falsely” ele-
vated before CS, as CS contributes considerable stress to 
the examinee. We have not observed any decrease in anxi-
ety following rigid CS examination. However, when a less 
painful flexible CS was performed, the patients’ anxiety 
was reduced.
It is in agreement with Seklehner et  al., who demon-
strated that in patients who anticipated rigid CS anxiety 
levels were higher comparing to flexible CS [25].
Sexual satisfaction
In our paper, we showed that sexual satisfaction is nega-
tively influenced by the anxiety and depression symptoms. 
We could also observe the negative impact of pain suscep-
tibility on SS score. Although we were not able to prove 
an independent influence of age on sexual satisfaction, we 
noted that patients who were not responding to SS ques-
tionnaire were older.
Sexual satisfaction scores provided that post-CSs were 
strongly associated with the previously described baseline 
SS level; however, a negative impact of the rigid CS on SS 
was observed. We observed that there was no change in SS 
levels after CS in patients undergoing flexible procedure. In 
rigid group, although there were no large differences in the 
general analysis, the paired evaluation of pre- and post-CS 
results showed a significant decrease in SS after rigid CS 
and demonstrated negative association with anxiety. Once 
more, post-CS SS was negatively related to depression. It 
clearly shows that rigid cystoscopy has a negative impact 
on patients’ sexual well-being.
It is widely known that satisfaction with sexual life is 
of great importance in the global assessment of quality 
of life made by adults [43, 44]. It helps to maintain satis-
faction within a relationship and to provide considerable 
emotional, psychological, and physical pleasure [28]. Any 
malignancy of the lower abdomen and pelvis may lead to 
sexual dysfunction due to psychogenic or organic causes 
[45]. It was reported that in patients after definitive ther-
apy for localized prostate cancer, physiologic sexual dys-
function impacted the quality of sexual intimacy, everyday 
interactions with women, sexual imagining and fantasy life, 
and self-perceptions of masculinity [46]. In BC patients’ 
group, reliable data regarding sexual function refer almost 
solely to patients treated because of muscle-invasive BC 
[8, 47]. Some studies show that prevalence of sexual dys-
function in NMIBC patients, which is the largest group of 
new BC diagnoses, is very high compared with an age- and 
gender-matched healthy population. What was also proven 
is that almost a quarter of the sexually active patients with 
NMIBC are afraid of harming their partner during sexual 
contact [6].
It was reported that rigid CS might transiently impair 
functional sexual performance and libido in ¾ sexually 
active patients [6, 29]. However, available data on CS 
impact on SS are meagre and do not include comparison 
between rigid and flexible CS.
Limitations
Our study has some limitations. The rigid cystoscopies 
were not performed by the same urologist. CS, such as 
every surgical procedure, may be performed slightly differ-
ently among urologists. As the patient’s discomfort may (to 
some extent) depend on the way, the CS is performed, and 
it could have some effect on the results. Second, study was 
conducted in one university centre and on a relatively small 
sample. However, the group was very homogenous. There 
might have been some qualification bias, as we included 
only patients that were able to fill out surveys without the 
help of the third parties. We also lost some of the partici-
pants for two reasons. Twenty three patients were unable 
to fill the initial questionnaires, which might have resulted 
from strong anxiety at the admission for CS. In addition, 
17 of the enrolled patients did not send the second copy of 
the questionnaires. It is possible that depressive patients 
were less willing to fill out the second copy of surveys, and, 
therefore, were not included in the analysis. Finally, there 
might have been some qualification bias, as we included 
only patients that were able to fill out surveys without the 
help of third parties. Possibly, the paper does not include a 
complete cross section of NMIBC patients. It is likely that 
the paper presents younger and also more sexually active 
group.
Conclusion
Our study provides the general characteristics of anxiety, 
depression symptoms, and sexual satisfaction of NMIBC 
patients. We show the superiority of flexible CS over the 
rigid one in terms of pain perception, but also in sexual sat-
isfaction or anxiety levels in male patients who were under 
cyclic surveillance after TURB because of NMIBC. Mod-
ern flexible video cystoscopes are characterized by excel-
lent image quality, and wide range of active tip deflection, 
which allows for visualization of whole bladder mucosa, 
especially the sites which are difficult to access using rigid 
CS. The improvement in patients’ comfort together with 
excellent diagnostic results obtained with modern flexible 
cystoscopes make them a method of choice for bladder 
examination in male patients.
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